Acrotech Biopharma patents expiration
1. Khapzory patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11541012 | ACROTECH BIOPHARMA | Compositions comprising disodium levofolinate |
Mar, 2039
(15 years from now) | |
Drugs and Companies using LEVOLEUCOVORIN ingredient
Market Authorisation Date: 19 October, 2018
Treatment: NA
Dosage: POWDER;INTRAVENOUS
More Information on Dosage
KHAPZORY family patents
